Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects

1 Aug 1993

Abstract excerpt

Alpha-fetoprotein (AFP), unconjugated oestriol (UE3), intact human chorionic gonadotrophin (intHCG), and the free beta subunit of chorionic gonadotrophin (F beta HCG) were investigated in a series of 21 chromosomally abnormal and 14 open neural tube defect pregnancies ascertained from a series of 14,000 prospectively collected maternal serum samples at 6-14 weeks' gestation. In 16 cases of Down's syndrome,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8284287
DOI: 10.1002/pd.1970130804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsPMID 8284287Read ↗

Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterSemantic proximity Read ↗

Second trimester serum tests for Down's Syndrome screeningSemantic proximity Read ↗

Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropinSemantic proximity Read ↗

Appropriate biochemical parameters in first-trimester screening for Down syndromeSemantic proximity Read ↗

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropinSemantic proximity Read ↗

DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTIONSemantic proximity Read ↗

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROMESemantic proximity Read ↗

Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcomeSemantic proximity Read ↗

Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement.Semantic proximity Read ↗

Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesSemantic proximity Read ↗

Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersSemantic proximity Read ↗

Prenatal maternal dried blood screening with α-fetoprotein and free β-human chorionic gonadotropin for open neural tube defect and Down syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.